InChI=1/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s